Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 86,550 | 94,135 | 112,250 | 113,335 | 118,904 |
| Cost of Goods | 36,640 | 39,369 | 46,179 | 52,516 | 51,252 |
| Gross Profit | 49,910 | 54,766 | 66,071 | 60,819 | 67,652 |
| Operating Expenses | 99,130 | 61,346 | 64,356 | 68,268 | 65,838 |
| Operating Income | -48,580 | -6,211 | 1,894 | -6,933 | 2,066 |
| Interest Expense | 4,917 | 3,536 | 3,591 | 2,548 | 1,540 |
| Other Income | -3,889 | -1,918 | -859 | 302 | -666 |
| Pre-tax Income | -57,386 | -11,665 | -2,556 | -9,179 | -140 |
| Income Tax | -686 | 740 | 859 | 337 | 148 |
| Net Income Continuous | -56,700 | -12,405 | -3,415 | -9,516 | -288 |
| Net Income | $-56,700 | $-12,405 | $-3,415 | $-9,516 | $-288 |
| EPS Basic Total Ops | -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
| EPS Basic Continuous Ops | -12.77 | -2.85 | -0.81 | -2.30 | -0.07 |
| EPS Diluted Total Ops | -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
| EPS Diluted Continuous Ops | -12.77 | -2.85 | -0.81 | -2.30 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.70 | 0.60 | 0.30 | 1.80 |
| EBITDA(a) | $6,638 | $1,273 | $9,172 | $922 | $9,967 |